Universal unlikely to make EU concessions for now in EMI deal
Vivendi's
Universal is not likely to offer remedies in phase 1, but is likely to do so in phase 2, said the person, who declined to be identified because of the sensitivity of the matter.
Friday is the last day for Universal to offer concessions to European Commission regulators, who are scheduled to decide whether to clear the $1.9 billion deal by March 23.
An extended probe could take up to four months.
(Reporting by Foo Yun Chee; editing by Rex Merrifield)
© Copyright Thomson Reuters 2024. All rights reserved.
Join the Discussion